Day 1 of the WFH Global Forum focused on confronting the limitations of therapy, from plasma to gene therapy, and discussing treatment for people with mild or moderate hemophilia, women and girls with bleeding disorders, and people with rare bleeding disorders. Talks on inequities in healthcare delivery globally and innovative access programs were also given.
Day 2 started with an inspiring keynote presentation by Andre Picard, award-winning health and public policy journalist. Picard emphasized the importance of remembering and learning from the past as we enter a new era of bleeding disorders treatments. The next sessions focused on different WFH programs, access to gene therapy globally, and new treatments and technologies in the pipeline.
The 13th Global Forum provided a unique opportunity for participants to come together and collectively reassess various therapeutic options—both established and new—and discuss challenges and opportunities for better care and treatment. To find out more about the 13th WFH Global Forum, please click here.
The 13th edition of the WFH Global Forum is supported by funding from BioMarin, CSL Behring, Pfizer, Sobi and Spark Therapeutics.